Representation of SK Capital in the acquisition of Perrigo’s API division
Our firm represented SK Capital in the acquisition of Perrigos (NYSE; TASE: PRGO) API division. For more information, click here.
Media center
August / 2017
August / 2017
Representation of Mapi Pharma in an investment round
Representation of Mapi Pharma, an Israeli clinical stage pharmaceutical company, in a $10 million investment round. For more information, click here.
August / 2017
Representation of Intec Pharma in a public offering
Representation of Intec Pharma (NASDAQ and TASE: NTEC), in a $57.5 million public offering. For more information, click here.
August / 2017
Representation of R2Net in its acquisition by Signet
Representation of R2Net, an Israeli e-commerce and diamond technology company, in its acquisition by the world’s largest jewelry retailer, Signet Jewelers (NYSE:SIG). For more information, click here.
July / 2017
Representation of Applitools in a funding round
Representation of Applitools, a leader in AI-powered automated visual testing and monitoring for mobile, web, and native apps, in an $8 million financing round. For more information, click here.
July / 2017
Representation of GamidaCell in a private financing round
Our firm represented GamidaCell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, in a $40 million private financing. For more information, click here.
July / 2017
Representation of NeuroDerm in its acquisition by Mitsubishi Tanabe Pharma
Representation of NeuroDerm (Nasdaq: NDRM) which was acquired by Mitsubishi Tanabe Pharma for $1.1 billion! Our firm was proud to be part of the largest acquisition of an Israeli pharmaceuticals company. For more information, click here.
